#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antisynthetase syndrome Neuropathic arthropathy Fungal infection Chronic myeloid leukaemia Pulmonary sarcoidosis Ovarian cancer stage III B precursor type acute leukaemia Usher's syndrome Short-bowel syndrome Haemophagocytic lymphohistiocytosis Vitamin B12 deficiency Leber's congenital amaurosis Adenocarcinoma gastric Osteochondrodysplasia Waldenstrom's macroglobulinaemia refractory More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Basic Information Stevens-Johnson syndrome – Treatment Mantle cell lymphoma refractory – Life with Disease Prolymphocytic leukaemia – Basic Information Familial amyotrophic lateral sclerosis – Trials in Disease Lymphangioma – Diagnostics Primary immunodeficiency syndrome – Treatment Urea cycle disorder Advanced systemic mastocytosis Langerhans cell sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bms-986442 Sar442970 Mitoxantrone HUMAN COAGULATION FACTOR XIII Estradiol Valerate Sodium Phenylbutyrate Aclidinium Bromide Tozinameran BMS-986470 Nicotinamide Ferumoxytol Dextrose Bp Fluocinolone Acetonide Zanamivir Ima402 SOFTISAN 378 Amitriptyline Hydrochloride Farletuzumab Ecteribulin BW-20805 Daratumumab More therapies…

    Learn about Your Condition

    Developmental hip dysplasia Tendon disorder Neurotrophic keratopathy Colon cancer stage III Neonatal respiratory failure Aphthous ulcer Lymphocytic lymphoma Hairy cell leukaemia recurrent Conjunctivitis allergic Partial seizures B-cell lymphoma recurrent Polycystic liver disease Cryoglobulinaemia Tetanus Venous thrombosis limb More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Kat Attica General Hospital

Kat Attica General Hospital

Nikis 2, Kifissia, 145 61, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • Ampicillin Sodium
    • Lidocaine Hydrochloride
    • POLYMYXIN B SULFATE
    Croatia Greece

  • Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

    Recruiting

    3 1 1
    Investigated Drugs:
    • DICLOFENAC POTASSIUM
    • Thiocolchicoside
    • Paracetamol
    Cyprus Greece

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study comparing diclofenac, orphenadrine and paracetamol combination versus diclofenac alone and orphenadrine-paracetamol combination in patients with acute low back pain

    Recruiting

    3 1 1
    Investigated Drugs:
    • DICLOFENAC POTASSIUM
    • Paracetamol
    Greece

  • Study on Dexamethasone and Sodium Chloride for Treating Severe Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    Belgium France Greece Spain

  • Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

    Recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Austria Bulgaria Croatia Czechia Germany Greece +9

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study on Flecainide and Amiodarone for Treating Atrial Fibrillation in Patients with Coronary Artery Disease and Ejection Fraction Over 35%

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    • Atrial fibrillation
    Investigated Drugs:
    • Amiodarone Hydrochloride
    • Flecainide Acetate
    Greece

  • Study Comparing Diclofenac and Thiocolchicoside Injection to Diclofenac Alone for Patients with Acute Moderate to Severe Low Back Pain

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Diclofenac Sodium
    • Thiocolchicoside
    Greece
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!